Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Anabolic steroids and SARMs can cause serious liver damage.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Certain compounds from Panax ginseng can block proteins that affect hair growth, potentially helping treat hair loss.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Finasteride negatively affects fish reproduction and gonadal development.

Finasteride changes androgen receptor location in rat epididymis without altering tissue structure.

The method effectively measures drug impact on DHT levels in prostate treatments.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Aromatase inhibitors cause male pattern hair loss in women.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Minoxidil can reduce functions related to androgen receptors.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Silencing SFRP1 alone promotes hair growth, but adding DKK1 does not help.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.